Breath-based biomarkers for mesothelioma may prove encouraging to detect asbestos cancer early and could save lives. Since researchers are studying the results, they don't recommend the widespread usage of the test. Malignant pleural mesothelioma- MPM is...

According to Italian research, an aggressive dose of advanced radiotherapy (radical Hemi-thoracic radiotherapy) can double the survival time of malignant pleural mesothelioma patients. Advanced and high dosage of radiotherapy at the affected location can increase the...

CAR-T cell Immunotherapy and PD- 1 treatment showed Remarkable Antitumor Activity with no Toxic Effects, An Update on the Ongoing Clinical Trials. Ongoing clinical trials (May 2015 till April 2020) on CAR- T cell (chimeric antigen receptors) therapy combined with PD-I...

According to the new Chinese research, soluble mesothelin-related peptide- SMRP is the best biomarker for the diagnosis of malignant mesothelioma in comparison with other biomarkers, regardless of its low sensitivity. Even though the sensitivity is low, but according...

Lumicell- Experts are testing a new innovative imaging technology at Massachusetts General Hospital. The imaging technology can enhance the vision of residual metastatic cancerous cells, and thus enables the surgeons to remove most of the cancerous cells in the...

About 70% of cancer patients suffer through insomnia at any point from cancer diagnosis to its treatment. This new study has shown that acupuncture and cognitive behavioral therapy (CBT) can be used as an efficient solution to tackle insomnia effectively in cancer...

After thoroughly studying the recent progression of chemotherapy and immunotherapy, the Australian researchers have called the combination of these two (immunochemotherapy) the "next frontier" to get better results in the treatment of mesothelioma cancer. This study...

Mesothelioma is a rare, and aggressive cancer affecting mainly the lungs, the area around the heart and abdomen, depending upon the subtype. A major cause of mesothelioma is excessive inhalation of devastating asbestos fibers. Patients suffering from mesothelioma...

The FDA has approved the NovoTTF-100L system combined with chemotherapy for the treatment of malignant pleural mesothelioma. The combination is the first treatment approved by the FDA for malignant pleural mesothelioma in 15 years. Non-invasive NovoTTF-100L is an...